The virulence levels attained by serial passage of pathogens through similar host genotypes are much higher than observed in natural systems; however, it is unknown what keeps natural virulence levels below these empirically demonstrated maximum levels. One hypothesis suggests that host diversity impedes pathogen virulence, because adaptation to one host genotype carries trade-offs in the ability to replicate and cause disease in other host genotypes. To test this hypothesis, with the simplest level of population diversity within the loci of the major histocompatibility complex (MHC), we serially passaged Friend virus complex (FVC) through two rounds, in hosts with either the same MHC genotypes (pure passage) or hosts with different MHC genotypes (alternated passage). Alternated passages showed a significant overall reduction in viral titre (31%) and virulence (54%) when compared to pure passages. Furthermore, a resistant host genotype initially dominated any effects due to MHC diversity; however, when FVC was allowed to adapt to the resistant host genotype, predicted MHC effects emerged; that is, alternated lines show reduced virulence. These data indicate serial exposure to diverse MHC genotypes is an impediment to pathogen adaptation, suggesting genetic variation at MHC loci is important for limiting virulence in a rapidly evolving pathogen and supports negative frequency-dependent selection as a force maintaining MHC diversity in host populations.
Introduction
Serial passage studies of pathogens have shown dramatic increases in virulence; however, the factors contributing to this virulence evolution are still unknown (Brown et al., 2001; Kawecki et al., 2012 . Genotype-specific adaptation may be a major cause of these order-ofmagnitude level virulence increases, as each experimental passage was performed through similar genotypes of hosts. The hypothesis that between-host genetic diversity can influence virulence was tested in a mouse-retrovirus system, and when host genotypes are alternated during serial passage, trade-offs occur as both fitness and virulence evolution are severely impeded (Kubinak et al., 2015) ; this provides an explanation for why the virulence of pathogens in nature seems to seldom reach the levels observed during serial passage studies in the laboratory. However, the previous study used mouse genotypes that differed across the entire genome, so that study was unable to identify any regions of particular importance for impeding virulence evolution in a small population context.
Classical major histocompatibility complex (MHC) genes are the most polymorphic loci known in vertebrates and play a critical role during immune recognition (Robinson et al., 2015) . The high degree of allelic diversity present in host populations is thought to be due to antagonistic co-evolution between hosts and their pathogens (Potts et al., 1994; De Boer et al., 2004) . Often referred to as Red Queen (RQ) dynamics, these interactions predict reciprocal patterns of selection whereby adaptations that benefit one species will favour counter-adaptations in the interacting species (Van Valen, 1973) . Furthermore, RQ dynamics may lead to maintenance of MHC diversity in populations through negative frequency-dependent selection, which will in turn control virulence in the host population because of the trade-offs associated with genotype-specific adaptation, that is specialization (Carius et al., 2001; MeyerLucht & Sommer, 2005; Sutton et al., 2011) .
MHC class I and class II genes allow for discrimination between self and nonself peptide antigens by encoding cell surface molecules that bind and present intracellular and extracellular peptides on the cell surface for interrogation by circulating T-lymphocytes (T cells) (Jeffery & Bangham, 2000; Wegner et al., 2003; Spurgin & Richardson, 2010 ). Recognition by a T cell expressing a cognate T-cell receptor to a given MHC-peptide complex triggers an adaptive immune response (Watts, 1997) . Consequently, circumventing antigen presentation by MHC molecules may be a primary means by which pathogens increase within-host growth rates (fitness) (Fruh et al., 1999) . For example, over 50% of genetic variants seen in HIV occur in MHC-presented epitopes (Pereyra et al., 2011; Henn et al., 2012) ; adaptation to escape specific MHCs could lead to trade-offs in pathogen fitness in hosts expressing different MHC molecules, due to the specialization of the viral pathogen on the first host leading to maladaptation in the second host. Multiple studies in mice have demonstrated that MHC polymorphisms influence the severity of disease associated with pathogen infection (i.e. virulence) (Meyer-Lucht & Sommer, 2005; Wedekind et al., 2006; . Furthermore, trade-offs in pathogen fitness associated with adaptation to specific MHC genotypes between multiple hosts may explain the association between virulence and MHC polymorphism (McClelland et al., 2003) .
Friend virus complex (FVC) is a mouse specific gamma-retrovirus that has been used extensively in immunological studies and more recently in experimental evolution studies (Kubinak et al., 2012b; Kubinak et al., 2015) . The complex is made up of two viral genomes that work synergistically to cause an erythro-proliferative disorder in susceptible mouse strains: the replication-competent Friend murine leukaemia virus (F-MuLV) and the replication-incompetent spleen focus-forming virus (SFFV) (Friend, 1957; Ruscetti, 1999) . FVC has been shown to adapt to specific host MHC genotypes through serial passage, which results in fitness and virulence trade-offs when hosts possessing different MHC genotypes are encountered (Kubinak et al., 2012b; Kubinak et al., 2015) . Evidence also suggests that loci within the MHC region account for a majority of the reduction in pathogen fitness and virulence associated with exposure to a novel host genotype ; however, the previously mentioned studies were performed by serially exposing FVC to a single MHC genotype through ten rounds of passage, which is unlikely to happen in wild host populations because of existing genetic variation at these loci.
Here, we test the simplest case of a population where we alternate virus between two different host MHC genotypes to determine whether MHC polymorphisms between two individuals is sufficient to reduce viral fitness and virulence. We hypothesize that passage of FVC through two hosts possessing unique MHC alleles will result in significantly lower viral fitness and virulence than virus serially exposed to the same MHC genotype. The work presented here builds upon previous evidence showing benefits of genomewide genetic diversity and suggests that between-host MHC diversity may be a major factor reducing pathogen virulence while being maintained through selective pressures imposed by pathogens interacting with host genotypes (Kubinak et al., 2012b (Kubinak et al., , 2013b (Kubinak et al., , 2015 .
Materials and methods

Mouse model
The Mus musculus animals used for the study were 2-to 6-month-old females purchased from Jackson Laboratories and bred under specific pathogen-free conditions. Three different MHC congenic strains of BALB/c mice were used: BALB/cByJ (Balb/c dd ), C.C3-H2k (Balb/c kk ) and C.B10-H2b (Balb/c bb ). Each independent experiment consisted of three viral passage lines with ten replicates per line, followed by a test phase again using ten replicates per passage line. All of the strains used were susceptible to FV infection; however, they had different susceptibility profiles with BALB/c bb being most resistant, BALB/c dd being least resistant and BALB/c kk being of intermediate resistance (Chesebro et al., 1990 . Furthermore, to keep animal numbers as low as possible and reduce animal waste, we did not control for mutations that may have occurred outside of the MHC region through the generations of breeding in the independent strains of mice, although this is an important aspect that should be controlled for in future experiments. All animals were housed and used in accordance with the University of Utah Institutional Animal Care and Use Committee (protocol # 04-08022).
Pathogen model
A previously described biological clone of an NB-tropic strain of Friend virus complex (FVC) was maintained in an NIH3T3 fibroblast cell line (biological clone) and used to generate all viral stocks used in the experiments (Kubinak et al., 2012b; Kubinak et al., 2015) . Unpassaged viral stocks were generated by harvesting viral cell supernatants from an infected NIH3T3 fibroblast cell line; this bioclone stock was passaged for two rounds through BALB/c dd animals to obtain a BALB/c ddadapted stock virus. Furthermore, due to the high mutation rates and large population sizes viruses are known to have, this two-round passage also increases viral diversity of the stock virus allowing for selection to act (Lauring & Andino, 2010; Domingo et al., 2012) . The two-round adapted stock was used to start all passage lines for each individual experiment, excluding the Balb/c bb -adapted two-round experiment. The tworound adapted stock was needed in order to maintain sustained animal-to-animal passage in more resistant Balb/c bb and Balb/c kk genotypes as the bioclone virus would not passage (data not shown). Spleen supernatants from the 14 animals infected in the second round were pooled in order to obtain enough volume to last the duration of the experiment. The pooled spleen supernatants were aliquoted and stored at À80°C. All viral stocks were kept on ice, and each aliquot was only thawed once.
Virulence estimates
FVC causes an erythro-proliferative disorder leading to gross enlargement of the spleen (splenomegaly) during acute infection. Thus, disease virulence (harm to host) was quantified by measuring spleen mass to the nearest hundredth of a gram.
Viral fitness estimates
Viral titre (retroviral genomes integrated into the host genome) was used as a proxy for viral fitness. Due to the correlated relationship between F-MuLV and SFFV (P = 0.014, R 2 = 0.41), we only generated F-MuLV titre data (Fig. S1 ). Viral titre was measured using the Roche Lightcycler 2.0 platform with primers previously published for this system (Kubinak et al., 2012b; Kubinak et al., 2015) . Detected F-MuLV viral genomes were normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPD) copies in order to obtain a standardized ratio of viral genomes per host genome copies. The viral genome by GAPD genome ratios was then multiplied by the spleen mass to obtain estimates of viral genomes per spleen.
Serial passage design
The initial passage rounds were created using either a two-round passaged stock virus or a Balb/c bb -adapted stock virus (described below) to infect, through intraperitoneal (I.P.) injection, 10 individual animals of each mouse strain. At 12 days postinfection, each animal was sacrificed, infected spleens were collected for viral load estimates, and measurements of disease were made. After organ mass was recorded, a portion of the spleen was saved in RNAlater TM and the rest combined in a 1:1 ratio of 19 phosphate-buffered saline (PBS) (i.e. 1 g of spleen was diluted in 1 ml PBS). The spleen-PBS mixture was mechanically homogenized. Homogenates were then centrifuged at 5000 RPM for 5 min, and virus-laden supernatants were collected and frozen at À80°C. In order to control for dose of the virus in the test phase, each viral inoculum was standardized by titering the supernatant and diluting it to the average titre of the alternating treatment group with the lowest average titre of its replicates; any inoculum under the average was used undiluted at a full dose (200 lL) while anything above the average was diluted before injection. Furthermore, it has been previously shown that there is no MHC graft effect of passaging viral proteins when the spleen supernatant is injected into a host with a novel MHC (Kubinak et al., 2015) .
Stock two-round alternating experiments
Experiments consisted of three independent subexperiments carried out in each BALB/c MHC congenic mouse strain (Balb/c dd , Balb/c kk and Balb/c bb ). In each, virus was passaged twice through animals possessing the same MHC genotype or twice through animals possessing different MHC genotypes (Fig. 1) . 200 lL of the stock virus was used to inoculate 10 animals of each MHC congenic strain (Round 1). After the infection period, the animals were killed and 20 lL of each individual spleen supernatant was used to infect an animal from each of the three MHC congenic host strains (Round 2). After the second infection period, the spleen supernatant was standardized and used to inoculate the original strain of passage (Test Phase). Three subexperiments were performed in total with each congenic strain of Mus acting as the control pure passage with their corresponding alternated passage lines through the other two MHC genotypes. In total, there were 70 infections with 30 independent passage lines in each of the three subexperiments, for a total of 210 infections.
Balb/c bb -adapted two-round alternating experiment
Due to the unexpected result shown in the Balb/c bb experiment, where fitness and virulence was reduced in all treatments in the test phase, we conducted another subexperiment with a FVC strain adapted to the Balb/c bb genotype. These additional experiments were performed to test whether the expected pattern where passages through alternating MHC genotypes reduces titre and virulence, holds true when the virus is sufficiently adapted to overcome some of the inherent host resistance. We used a previously generated virus that was adapted to the Balb/c bb host genotype through ten rounds of passage in order to obtain a sufficiently adapted virus (Kubinak et al., 2012b; Kubinak et al., 2015) . The previously described Balb/c bb experiment was repeated with the new Balb/c bb stock adapted through ten rounds of passage. Again, three different passage treatments were conducted, in which the virus was passaged through either pure-passage lines (Balb/ c bb in each round) or alternating passage lines (different MHC genotype in the second round of passage, Balb/ c kk or Balb/c dd ). Again, a test phase was conducted in the original host strain of passage with the same dilution scheme, to test for differences between passage treatments.
Statistics
All statistical analyses were completed in R (3.3.1) (R Core Team, 2016) . Titre data were multiplied by spleen mass to obtain total viral titre per spleen estimates and spleen mass, and titre data were log 10 transformed due to its non-normal nature. Data pooled between the initial stock two-round experiments were analysed using linear mixed models (LMMs) in the LME4 package with response variables of either viral titre or spleen mass and a fixed effect of treatment (Bates et al., 2014) . Random effects of host genotype and litter were included in order to control for variation due to different resistance patterns in the host strains between experiments and to control for potential variation in genomic and maternal investment between breeding cage, as rederivation of each homozygote line was not feasible; P-values were obtained using the R package LMERTEST (2.0-33) (Table S1 ) (Kuznetsova et al., 2016) . Furthermore, each individual stock two-round experiment was analysed by a one-way ANOVA with corresponding Tukey post hoc tests to determine differences between each treatment group. The Balb/c bb -adapted experiment was analysed separately from the two-round alternating experiments and was analysed by a one-way ANOVA with post hoc Tukey tests to determine differences between passage lines. All data in figures represent mean AE SEM. Data is available on DRYAD (https://doi. org/10.5061/dryad.3h0q8).
Results
Stock two-round MHC alternating passages
Pooling data from each of the MHC experiments shows a significant reduction in viral fitness and virulence when the virus went through an alternated passage regime vs. a pure-passage regime. FVC stocks derived from alternated passage demonstrated a 31% reduction in titres compared to pure-passaged FVC (LMM; t = À3.13, P = 0.003) (Fig. 2a) . Furthermore, virulence of FVC was reduced by 55% in alternating passages when compared to pure-passage lines (LMM; t = À3.40, P = 0.002) (Fig. 2b) .
Viral titre measures demonstrated a statistically significant overall reduction in fitness in alternated passages when the three-two-round stock experiments are pooled; however, not all comparisons for each individual experiment were significant (Fig. 3a-c) . The Balb/ c dd experiment showed a significant difference in viral titre between the experimental groups ( Fig. 3a ) (ANOVA; F (2,31) = 4.9, P = 0.01). Specifically, there was a significant reduction in FVC titre when passaged through both alternated Balb/c bb (Tukey, P = 0.02), and alternated Balb/c kk lines (Tukey, P = 0.05) relative to purepassage lines. Similarly, when FVC was passaged in the Balb/c kk experiment, there were significant differences between viral titre of experimental groups (Fig. 3b ) (ANOVA; F (2,21) = 11.4, P < 0.001). In this case, a 
significant reduction in viral titre was observed only when FVC was passaged through the Balb/c bb genotype when compared to pure-passage lines (Tukey, Balb/c bb , P < 0.001; Balb/c dd , P = 0.12). The Balb/c bb experiment did not show the predicted effect, and there was actually an increased viral titre when FVC was passaged through the alternating Balb/c dd genotype (Fig. 3c ) (fitness, ANOVA, F (2,24) = 10.4, P < 0.001; Tukey, Balb/c dd , P = 0.02, Balb/c kk , P = 0.27). Virulence measures showed similar results to the titre data; the overall data showed alternating passages had a statistically significant virulence reduction compared to pure passages; however, the trend was not consistent in each individual alternating passage in each experiment. The Balb/c dd subexperiment showed a statistically significant relationship between groups (Fig. 3d) (ANOVA; F (2,39) = 4.9, P = 0.013); however, there was only a statistically significant reduction in virulence when FVC was passaged through the alternated Balb/ c bb lines (Tukey, P = 0.009) and only slightly reduced in the alternated Balb/c kk lines (Tukey, P = 0.225). The Balb/c kk subexperiment also showed a statistically significant relationship between groups (ANOVA; F (2,25) = 8.1, P = 0.002) with each of the alternated lines showing reduced virulence, but only the Balb/c bb lines showing statistically significant reductions (Fig. 3e) (Balb/c bb Tukey, P = 0.001; Balb/c dd Tukey, P = 0.270). Again, the Balb/c bb stock experiment did not show a reduction in virulence in alternating passages, and there was an increase when the virus went through an alternating Balb/c dd passage (Fig. 3f ) (ANOVA, F (2,27) = 10.9, P < 0.001; Tukey; Balb/c dd , P < 0.001). 
Two-round Balb/c bb -adapted experiment
In the experiment using a Balb/c bb -adapted virus, an overall reduction in both titre and virulence was observed when FVC was passaged through animals with alternated MHC genotypes, although again not statistically significant in each alternating passage (fitness, ANOVA; F (2,23) = 20.3, P < 0.0001; virulence, ANOVA; F (2,27) = 19.7, P < 0.0001; Fig. 4) . Individually, there was only a significant reduction in titre and virulence when passaged through the Balb/c kk haplotype (titre, Tukey P < 0.0001; virulence, Tukey, P < 0.0001) (Fig. 4a,b) . Passaging FVC through the Balb/c dd genotype did show a slight reduction in both titre and virulence; however, this reduction was not significant (Tukey; titre, P = 0.93; virulence, P = 0.97).
Discussion
The data presented here support the hypothesis that increased MHC diversity in host populations impedes pathogen adaptation as evidenced by reduced fitness and virulence. Although we do not see significant reduction in viral titre and virulence in each individual alternating passage, in general there is an overall 31% reduction in viral titre and 54% reduction in virulence when FVC is passaged through alternated hosts compared to pure-passage hosts when variation between experiments is controlled using a LMM (Fig. 2) . The reductions in virulence observed here provide a mechanism for how pathogens, forced to adapt to multiple MHC genotypes encountered in natural populations, are not able to attain the virulence that has been observed in serial passages through isogenic hosts.
The initial two-round stock Balb/c bb experiment did not show the predicted pattern; this may be due to the high resistance of the Balb/c bb overshadowing the alternating MHC effects . If true, then a virus more adapted Balb/c bb might allow the predicted pattern to emerge. To test this hypothesis, we repeated the Balb/c bb experiment with a Balb/c bb -adapted virus serially passaged through ten rounds. When FVC has been able to adapt to the Balb/c bb genotype, our hypothesized pattern emerges: there is a reduction in fitness and virulence in the alternated lines when compared to the pure-passage lines, although only significant in the Balb/c kk alternated lines. Interestingly, the virus alternated through Balb/c dd had significantly higher virulence and titre in the test phase than pure passage, suggesting the susceptibility of MHC genotypes is an important interacting variable. These experimental data are consistent with other correlative studies showing a reduction in pathogen load when many different MHC alleles are present in a population, such as in the yellow-necked mouse and European badger systems (Meyer-Lucht & Sommer, 2005; Sin et al., 2014) . Furthermore, by allowing the virus to adapt to the most resistant MHC genotype, making these hosts more susceptible, we experimentally support the negative frequency-dependent predictions of the RQ hypothesis, demonstrating the dynamic character of such co-evolutionary interactions De Boer et al., 2004) .
MHC diversity is thought to be maintained in vertebrate populations through three nonmutually exclusive mechanisms: nonrandom mate preference, heterozygote advantage and negative frequency-dependent selection (Kubinak et al., 2012a; Brockhurst et al., 2014) . Here, we provide evidence for negative frequency-dependent selection in two ways. First, as MHC genotypes are alternated during serial passage of the virus, they supply a different selective pressure than the pure passage causing the virus to experience a fitness trade-off when each new MHC genotype is adapted to by the virus. These trade-offs are essential for establishing molecular arms races and give rise to the attendant negative frequency-dependent selection. Second, the initial experiment through the resistant Balb/c bb genotype did not show reduced titre or virulence during alternated passages (compared to pure passages). However, FVC is capable of adapting to the most resistant MHC genotype (Balb/c bb ) when passaged through ten rounds, thereby making it more susceptible and allowing the expected patterns of reduced virulence during alternated passages to emerge . The adapted Balb/c bb experiment models what might be expected in populations where the rare MHC alleles are initially not the targets of pathogen adaptation, but over time they become more common and consequently less resistant because they are now more frequent targets of pathogen adaptation. However, this dynamic is not seen in the initial experiment because hosts genotypes in their high resistance (rare) phase can dominate and overwhelm typical MHC-specific virulence patterns. Although the results presented here do not completely rule out other hypotheses that may be maintaining MHC diversity in populations, it does show that negative frequency-dependent selection is one force maintaining diversity and that more work needs to be completed.
These data demonstrate that population-level MHC diversity is beneficial to hosts because it reduces virulence evolution. It follows that a selective advantage will arise in families where both parents are MHC dissimilar because virulence is reduced as it moves through the different MHC genotypes of a family, providing a familial-level function for MHC-dissimilar mating preferences (Potts et al., 1991; Eizaguirre et al., 2009; Lenz et al., 2009) .
In many serial passage studies from Daphnia to mice, virulence has been shown to increase by orders of magnitude (Ebert & Bull, 2003 , Kubinak et al., 2012b Kubinak et al., 2015 , Kawecki et al., 2012 ; however, the underlying mechanism of this adaptation is unknown. We provide evidence that the increases in virulence of FVC are due, at least in part, to specialization of the pathogen through specific MHC genotype adaptation. MHC plays a major role in the interactions pathogens have with hosts and as the pathogen increases in virulence by adapting to one specific MHC genotype it incurs trades-offs in other MHC genotypes (Kubinak et al., 2012b; Kubinak et al., 2015) . The 54% reduction in virulence observed when the pathogen is passaged through two hosts with dissimilar MHC genotypes supports the hypothesis that diversity at MHC loci is a controlling factor for virulence evolution. Increasing the amount of MHC diversity in host populations provides an advantage for each individual in that population as it reduces the probability a pathogen that infects them will have seen a similar MHC genotype during the previous infection.
Serial passage is a useful tool in co-evolution studies, and many have shown an increase in fitness and virulence of various pathogens using these techniques (Ebert, 1998; De Bruin et al., 2008; Mackinnon et al., 2008; Wei et al., 2014) . Many of these studies have focused on pathogen interactions with species changes or sexual vs. asexual passages, but not passages of pathogens through different genotypes of the same vertebrate host species, as was done here (Coffey & Vignuzzi, 2011; Ciota et al., 2015) . Furthermore, only a few of these serial passage studies have incorporated MHC allelic diversity into their passage schemes, which is thought to cause pathogen fitness trade-offs through antagonistic relationships when the number of MHC alleles are increased in populations (Radwan et al., 2010) . Only Kubinak et al. has provided experimental evidence that between-host genetic diversity reduces pathogen fitness and virulence in a vertebrate Mus host; however, this work was carried out with hosts that differed throughout the genome, not just at the MHC region (Kubinak et al., 2015) . Confirming strong effects of MHC diversity alone during experimental evolution highlights the importance MHC-specific adaptations have on viral evolution and represents the first experimental demonstration of diversity at specific loci impeding pathogen virulence evolution.
Although this study shows a strong relationship between MHC diversity and pathogen evolution, we do not take into account natural transmission or other pathogens. Removal of the cost of transmission could lead to increased virulence of the pathogen; however, evidence suggests this is not causing the effect in our system (Ebert & Bull, 2003; Alizon et al., 2009) . As host genotypes are alternated, we see a trade-off in the new hosts with the same transmission route, suggesting that viral interactions with the host MHC genotype are driving the adaptations and trade-offs independent of removing the cost of transmission (Fig. 2) . Unfortunately, the relative importance of transmission and host genetics in virulence evolution is not known and needs to be investigated further. Moreover, FVC is a laboratory strain of virus and may not be found in this form in natural systems; however, other viruses such as dengue virus have replication-incompetent particles that enhance virulence much like SFFV does in FVC (Ke et al., 2013) . Furthermore, due to its similar life cycle, FVC is a good model to use to understand other ecologically relevant retroviruses, such as human immunodeficiency virus, Simian immunodeficiency virus, bovine leukaemia virus and koala retrovirus (Pollari et al., 1992; Tarlinton et al., 2006; Myers & Hasenkrug, 2009; Hartmann, 2012) . Future work should focus on the relationships between naturally transmitting pathogens and population-wide MHC diversity to understand the relative importance each plays in their co-evolutionary system.
Here, we demonstrate that RQ dynamics control virulence evolution by showing trade-offs in FVC fitness and virulence when it encounters a host with a novel MHC genotype. These data suggest that the high virulence seen in serial passage studies may not be seen in nature due to the continual selection placed on the virus with each transmission event into a host with a novel MHC genotype. Furthermore, as the virus adapts to the most resistant (common) genotype, we observed MHC trade-offs emerge when new (alternating) genotypes are encountered, as would be expected through negative frequency-dependent selection. These data shed light on the importance host pathogen co-evolutionary relationships play in the maintenance of MHC diversity and how this diversity is important for virulence evolution, having practical implications for endangered and agricultural species through their respective breeding programmes (Frankham, 2010) .
